Growth Metrics

Entera Bio (ENTX) Depreciation and Depletion (2018 - 2025)

Entera Bio has reported Depreciation and Depletion over the past 8 years, most recently at $7000.0 for Q4 2025.

  • For the quarter ending Q4 2025, Depreciation and Depletion fell 36.36% year-over-year to $7000.0, compared with a TTM value of $30000.0 through Dec 2025, down 34.78%, and an annual FY2025 reading of $30000.0, down 34.78% over the prior year.
  • Depreciation and Depletion came in at $7000.0 for Q4 2025, down from $8000.0 in the prior quarter.
  • In the past five years, Depreciation and Depletion ranged from a high of $16000.0 in Q1 2022 to a low of $7000.0 in Q2 2025.
  • Median Depreciation and Depletion over the past 5 years was $13500.0 (2021), compared with a mean of $12450.0.
  • The largest YoY upside for Depreciation and Depletion was 115.73% in 2021 against a maximum downside of 82.0% in 2021.
  • Over 5 years, Depreciation and Depletion stood at $14000.0 in 2021, then increased by 14.29% to $16000.0 in 2022, then fell by 18.75% to $13000.0 in 2023, then decreased by 15.38% to $11000.0 in 2024, then crashed by 36.36% to $7000.0 in 2025.
  • Per Business Quant, the three most recent readings for ENTX's Depreciation and Depletion are $7000.0 (Q4 2025), $8000.0 (Q3 2025), and $7000.0 (Q2 2025).